当前位置: 首页 > 期刊 > 《中国实用医药》 > 2011年第34期 > 正文
编号:12182058
2型糖尿病患者HbA1c达标与病程的关系(2)
http://www.100md.com 2011年12月5日 吴美芬 武革 陈文璞 蔡晓玲 陈晓铭 方烁 邹艺
第1页

    参见附件。

     本研究结果表明,我院随机就诊的T2DM患者HbA1c达标率低,长病程的T2DM患者的HbA1c达标率更低,提示临床应对这些长病程患者加强血糖监测和降糖方案的调整,促进HbA1c达标。

    参 考 文 献

    [1] Bretzel RG, Nuber U, Landgraf W, et al. Oncedaliy babsl insulin glargine versus thricedaliy prandial insulin lispro in people with type 2 diabetes on oralhypoglycaemic agents (APOLLO):an open randomized controlled trial. Lancet,2008,371(9618):10731084.

    [2] Pan C, Yang W, Jia W, et al. Management of Chinese patients with type 2 diabetes, 19982006: the DiabcareChina surveys. Curr Med Res Opin, 2009, 25:(1) :3945.

    [3] Stratton I M, Adler A I, Nen H A, et al. Association of glycaemia with macrovascular complications of type 2 diabetes(UKPDS 35) :prospective observational study. BMJ, 2000,321(7258) :405412.

    [4] Fox KM, Gerber Pharmd R A, Bolinder B, et al. Prevalence of inadequate glycemic control among patients with type 2 diabetes in the United Kingdom general practice research database:a series of retrospective analyses of data from 1998 through 2002. Clin Ther, 2006, 8 (3) :388395.

您现在查看是摘要介绍页,详见PDF附件(2382kb)